Philippe Camus, M.D.
Dijon, France
X - Pulmonary edema
Last update 17/06/2026
See under Xab. The syndrome includes fever, weight gain, peripheral edema, respiratory distress, interstitial pulmonary opacities, pleural and/or pericardial effusions, hypotension and renal failure. See also under IIb (ARDS) and Va
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
X. Pulmonary edema
X.i Pulmonary edema/ARDS of the ATRA syndrome
X. Pulmonary edema
X.j The differentiation- or ATRA syndrome
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XII. Pericardial involvement
XII.n Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)
XIII. Thrombosis - Embolism
XIII.a Pulmonary embolism - Venous thrombosis/thrombo-embolism
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
X. Pulmonary edema
X.d Fluid retention
X. Pulmonary edema
X.i Pulmonary edema/ARDS of the ATRA syndrome
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
